Filing Details

Accession Number:
0001567619-18-002900
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-19 17:54:32
Reporting Period:
2018-09-18
Accepted Time:
2018-09-19 17:54:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
70487 National Research Corp NRC Services-Commercial Physical & Biological Research (8731) 470634000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522907 R Kevin Karas C/O National Research Corporation
1245 &Quot;Q&Quot; Street
Lincoln NE 68508
Svp Finance, Cfo, Treas & Secy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-09-18 4,065 $39.71 16,051 No 4 S Direct
Common Stock Disposition 2018-09-19 735 $38.52 15,316 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Option (right to buy) $10.75 2022-01-05 26,403 26,403 Direct
Common Stock Employee Stock Option (right to buy) $14.50 2023-01-07 20,088 20,088 Direct
Common Stock Employee Stock Option (right to buy) $18.80 2024-01-07 5,334 5,334 Direct
Common Stock Employee Stock Option (right to buy) $13.17 2025-01-06 19,313 19,313 Direct
Common Stock Employee Stock Option (right to buy) $15.23 2026-01-05 20,458 20,458 Direct
Common Stock Employee Stock Option (right to buy) $18.80 2027-01-04 16,728 16,728 Direct
Common Stock Employee Stock Option (right to buy) $36.80 2028-01-03 11,617 11,617 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-01-05 26,403 26,403 Direct
2023-01-07 20,088 20,088 Direct
2024-01-07 5,334 5,334 Direct
2025-01-06 19,313 19,313 Direct
2026-01-05 20,458 20,458 Direct
2027-01-04 16,728 16,728 Direct
2028-01-03 11,617 11,617 Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually received ranged from $39.50 to $39.90. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $38.50 to $38.55. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
  3. This option became fully exercisable on January 5, 2017.
  4. This option became fully exercisable on January 7, 2018.
  5. This option becomes fully exercisable on January 7, 2019.
  6. This option becomes fully exercisable on January 6, 2020.
  7. This option becomes fully exercisable on January 5, 2021.
  8. This option becomes fully exercisable on January 4, 2022.
  9. This option becomes fully exercisable on January 3, 2023.